These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28729760)

  • 1. Structural insight into the binding of C60-derivatives with enoyl-pyruvate transferase from Helicobacter pylori.
    Teimouri M; Junaid M; Khan A; Zhang H
    Bioinformation; 2017; 13(6):185-191. PubMed ID: 28729760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
    Tabassum H; Ahmad IZ
    Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking Approach.
    Junaid M; Almuqri EA; Liu J; Zhang H
    PLoS One; 2016; 11(2):e0147761. PubMed ID: 26829126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fullerene derivatives act as inhibitors of leukocyte common antigen based on molecular dynamics simulations.
    Yu Y; Sun H; Hou T; Wang S; Li Y
    RSC Adv; 2018 Apr; 8(25):13997-14008. PubMed ID: 35539330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
    Skariyachan S; Parveen A; Garka S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomic level and structural understanding of natural ligands inhibiting
    Sunder Raj D; Kesavan DK; Kottaisamy CPD; Kumar VP; Hopper W; Sankaran U
    J Biomol Struct Dyn; 2023 May; 41(8):3440-3461. PubMed ID: 35293845
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
    Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
    J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and potent inhibitors for dihydropteroate synthase of
    Satuluri SH; Katari SK; Pasala C; Amineni U
    J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures.
    Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J
    Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium.
    Kataria R; Khatkar A
    Curr Top Med Chem; 2019; 19(29):2658-2675. PubMed ID: 31724503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a
    Martini C; Araba V; Beniani M; Armoa Ortiz P; Simmons M; Chalbi M; Mellouk A; El Bakkouri M; Calmettes C
    mBio; 2024 Mar; 15(3):e0295223. PubMed ID: 38376163
    [No Abstract]   [Full Text] [Related]  

  • 12. Search for Potential Inducible Nitric Oxide Synthase Inhibitors with Favorable ADMET Profiles for the Therapy of Helicobacter pylori Infections.
    Rodrigues RP; Ardisson JS; Ribeiro Gonçalves RC; Oliveira TB; Barreto da Silva V; Kawano DF; Kitagawa RR
    Curr Top Med Chem; 2019; 19(30):2795-2804. PubMed ID: 31721712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification and analysis of potential inhibitors for acid phosphatase, HppA from Helicobacter pylori.
    Sisodia R; Mazumdar PA; Madhurantakam C
    J Mol Recognit; 2023 Sep; 36(9):e3049. PubMed ID: 37553866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
    Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
    Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases.
    Rostami H; Haddadi MH
    Fundam Clin Pharmacol; 2022 Dec; 36(6):930-943. PubMed ID: 35716372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
    Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
    BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
    Graham DY; Genta RM; Graham DP; Crabtree JE
    J Clin Pathol; 1996 Oct; 49(10):829-32. PubMed ID: 8943750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
    Mandal RS; Das S
    J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet
    Bagheri N; Shirzad H; Mirzaei Y; Nahid-Samiei M; Sanaei M; Rahimian G; Shafigh M; Zandi F; Tahmasbi K; Razavi A
    Arch Med Res; 2019 Apr; 50(3):113-121. PubMed ID: 31495388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.
    Jhala D; Jhala N; Lechago J; Haber M
    Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.